118 related articles for article (PubMed ID: 9088758)
1. Newborn screening for neuroblastoma.
Parker L
Curr Opin Pediatr; 1997 Feb; 9(1):70-3. PubMed ID: 9088758
[TBL] [Abstract][Full Text] [Related]
2. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma screening data. An epidemiologic analysis.
Goodman SN
Am J Dis Child; 1991 Dec; 145(12):1415-22. PubMed ID: 1669671
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
5. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan.
Ajiki W; Tsukuma H; Oshima A; Kawa K
Cancer Causes Control; 1998 Dec; 9(6):631-6. PubMed ID: 10189049
[TBL] [Abstract][Full Text] [Related]
6. Is neuroblastoma screening evaluation needed and feasible?
Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
[TBL] [Abstract][Full Text] [Related]
7. Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2106-12. PubMed ID: 9516863
[TBL] [Abstract][Full Text] [Related]
8. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma: the case for screening infants in North America.
Woods WG; Tuchman M
Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
[TBL] [Abstract][Full Text] [Related]
13. Compliance in a screening program for neuroblastoma.
Campion P; Woods WG; Lemieux B
Prev Med; 1998; 27(4):590-6. PubMed ID: 9672953
[TBL] [Abstract][Full Text] [Related]
14. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
[No Abstract] [Full Text] [Related]
15. Screening for neuroblastoma: 20 years and still no answer.
Craft AW; Parker L
Eur J Cancer; 1996 Aug; 32A(9):1540-3. PubMed ID: 8911115
[No Abstract] [Full Text] [Related]
16. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma screening at one year of age.
Schilling FH; Spix C; Berthold F; Erttmann R; Fehse N; Hero B; Klein G; Sander J; Schwarz K; Treuner J; Zorn U; Michaelis J
N Engl J Med; 2002 Apr; 346(14):1047-53. PubMed ID: 11932471
[TBL] [Abstract][Full Text] [Related]
18. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
[TBL] [Abstract][Full Text] [Related]
19. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
20. Screening infants for neuroblastoma in North America.
McWilliams NB
Pediatrics; 1987 Jun; 79(6):1048-9. PubMed ID: 3588129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
